Emergent BioSolutions Inc.
USD8.38
-0.09 (-1.00%)
CEO
Joseph C. Papa Jr.
IPO Date
2006-11-15
Sector
Healthcare
Industry
Biotechnology
Exchange
NYSE
Country
US
Open
$8.39
Prev. Close
$8.46
Day Low
$8.21
Day High
$8.43
52W Low
$5.62
52W High
$14.06
Market Cap
$0.43B
Volume
0.08M
| -2.7 |
| 31 Dec 2023 | FY | 34.3% | -72.5% | -117.1% | -41.7% | 1.32 | 1.04 | -0.2 |
| 31 Dec 2022 | FY | 42.3% | -18.9% | -15.2% | -6.7% | 1.03 | 0.98 | -2.8 |
| 31 Dec 2021 | FY | 44.7% | 12.4% | 13.6% | 7.4% | 0.54 | 3.40 | 10.6 |
| 31 Dec 2020 | FY | 54.7% | 19.4% | 21.1% | 10.6% | 0.64 | 3.11 | 15.4 |
| 31 Dec 2019 | FY | 43.7% | 4.9% | 5.0% | 2.3% | 0.77 | 3.17 | 51.0 |
| 31 Dec 2018 | FY | 41.0% | 8.0% | 6.2% | 2.8% | 0.79 | 3.10 | 47.4 |
| 31 Dec 2017 | FY | 50.6% | 14.7% | 9.1% | 7.7% | 0.01 | 4.85 | 23.5 |
| 31 Dec 2016 | FY | 50.1% | 10.6% | 8.7% | 5.3% | 0.45 | 4.82 | 25.5 |
| -3.0 |
| 30 Sept 2025 | Q3 | 55.9% | 22.2% | 8.8% | 3.5% | 1.14 | 5.76 | 2.3 |
| 30 Jun 2025 | Q2 | 40.8% | -8.5% | -2.2% | -0.8% | 1.26 | 5.66 | -7.2 |
| 31 Mar 2025 | Q1 | 52.4% | 30.6% | 12.3% | 4.8% | 1.20 | 6.32 | 1.0 |
| 31 Dec 2024 | Q4 | 70.1% | -16.1% | -6.5% | -2.2% | 1.40 | 3.69 | -4.1 |
| 30 Sept 2024 | Q3 | 55.9% | 39.1% | 22.6% | 7.8% | 1.33 | 2.88 | 1.0 |
| 30 Jun 2024 | Q2 | -25.7% | -111.2% | -73.3% | -18.7% | 2.27 | 1.06 | -0.3 |
| 31 Mar 2024 | Q1 | 46.9% | 3.0% | 1.4% | 0.5% | 1.39 | 1.08 | 3.3 |
| 31 Dec 2023 | Q4 | 61.2% | -17.9% | -7.6% | -2.7% | 1.35 | 1.04 | -0.6 |